• 1425 Citations
  • 19 h-Index
19962020
If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 私立台北醫學院醫學系學士

Research Interests

  • 心臟血管急重症學
  • 超音波心圖學
  • 診斷治療性心導管術

Fingerprint Dive into the research topics where Ting-Hsing Chao is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 38 Similar Profiles
Taiwan Medicine & Life Sciences
Thrombomodulin Medicine & Life Sciences
Myocardial Infarction Medicine & Life Sciences
Coronary Artery Disease Medicine & Life Sciences
Hydroxymethylglutaryl-CoA Reductase Inhibitors Medicine & Life Sciences
Blood Vessels Medicine & Life Sciences
Guidelines Medicine & Life Sciences
Endothelial Cells Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2003 2020

Research Output 1996 2019

  • 1425 Citations
  • 19 h-Index
  • 96 Article
  • 5 Review article
  • 2 Letter
  • 1 Comment/debate

A subanalysis of Taiwanese patients from ODYSSEY South Korea and Taiwan study evaluating the efficacy and safety of alirocumab

Chao, T-H., Hsiao, P. J., Liu, M. E., Wu, C. J., Chiang, F. T., Chen, Z. C., Chen, C. P., Yeh, H. I., Lee, T. H. & Chiang, C. E., 2019 Jan 1, In : Journal of the Chinese Medical Association. 82, 4, p. 265-271 7 p.

Research output: Contribution to journalArticle

Republic of Korea
Taiwan
LDL Cholesterol
Safety
Placebos

The role of vascular smooth muscle cell membrane-bound thrombomodulin in neointima formation

Wang, K. C., Chen, P-S., Chao, T-H., Luo, C. Y., Chung, H. C., Tseng, S. Y., Huang, T. Y., Lin, Y. L., Shi, G. Y., Wu, H-L. & Li, Y-H., 2019 Aug 1, In : Atherosclerosis. 287, p. 54-63 10 p.

Research output: Contribution to journalArticle

Thrombomodulin
Neointima
Vascular Smooth Muscle
Smooth Muscle Myocytes
Cell Membrane
5 Citations (Scopus)

2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases

Chiang, C. E., Lin, S. Y., Lin, T. H., Wang, T. D., Yeh, H. I., Chen, J. F., Tsai, C. T., Hung, Y. J., Li, Y-H., Liu, P-Y., Chang, K. C., Wang, K. L., Chao, T-H., Shyu, K. G., Yang, W. S., Ueng, K. C., Chu, P. H., Yin, W. H., Wu, Y. W., Cheng, H. M. & 7 others, Shin, S. J., Huang, C. N., Chuang, L. M., Lin, S. J., Yeh, S. J., Sheu, W. H. H. & Lin, J. L., 2018 Mar 1, In : Journal of the Chinese Medical Association. 81, 3, p. 189-222 34 p.

Research output: Contribution to journalArticle

Cardiology
Taiwan
Type 2 Diabetes Mellitus
Cardiovascular Diseases
Pharmacology
9 Citations (Scopus)

A randomized trial evaluating the efficacy and safety of alirocumab in South Korea and Taiwan (ODYSSEY KT)

Koh, K. K., Nam, C. W., Chao, T-H., Liu, M. E., Wu, C. J., Kim, D. S., Kim, C. J., Li, I., Li, J., Baccara-Dinet, M. T., Hsiao, P. J. & Chiang, C. E., 2018 Jan 1, In : Journal of Clinical Lipidology. 12, 1, p. 162-172.e6

Research output: Contribution to journalArticle

Republic of Korea
Taiwan
Safety
LDL Cholesterol
Placebos
14 Citations (Scopus)
clopidogrel
Taiwan
Myocardial Infarction
Hemorrhage
Safety